Director, Transfusion Medicine/Blood Bank Director, Clinical Laboratories
Pathology
Dr. Neil H. Blumberg, MD
|
|
Give Review
Neil Blumberg practices Pathology. He attended Yale University School of Medicine. Yale University School of Medicine is a top medical college. Yale University School of Medicine has a rank of 7 in research and a 57 in primary care Neil Blumberg is also published. He has 67 publications published. The lastest publication: "The transfusion immunomodulation theory: the Th1/Th2 paradigm and an analogy with pregnancy as a unifying mechanism.'
Publications
- Resveratrol preserves the function of human platelets stored for transfusion.
- Platelet Transfusion and Thrombosis: More Questions than Answers.
- Significant Variation in Blood Transfusion Practice Persists following Upper GI Cancer Resection.
- ABO-immune complex formation and impact on platelet function, red cell structural integrity and haemostasis: an in vitro model of ABO non-identical transfusion.
- ABO matching of platelet transfusions - "Start Making Sense".
- Removal of biologic response modifiers associated with platelet transfusion reactions: strategies worth considering?
- Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis.
- Transfusion immunomodulation from a clinical perspective: an update.
- Isoprostane and isofuran lipid mediators accumulate in stored red blood cells and influence platelet function in vitro.
- Association between surgical resident involvement and blood use in noncardiac surgery.
- The transfusion dilemma - Weighing the known and newly proposed risks of blood transfusions against the uncertain benefits.
- Transfusion immunomodulation--the case for leukoreduced and (perhaps) washed transfusions.
- Platelets-to transfuse or not to transfuse.
- CD40 ligand (CD154) involvement in platelet transfusion reactions.
- An association of ABO non-identical platelet and cryoprecipitate transfusions with altered red cell transfusion needs in surgical patients.
- Platelet transfusions: trigger, dose, benefits, and risks.
- New frontiers in transfusion biology: identification and significance of mediators of morbidity and mortality in stored red blood cells.
- Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes.
- An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementati...
- Nuclear emancipation: a platelet tour de force.
- Aspirin resistance following pediatric cardiac surgery.
- Leukoreduction of blood transfusions--there is such a thing as a free lunch.
- Lack of significant de novo HLA allosensitization in ventricular assist device recipients transfused with leukoreduced, ABO identical blood products.
- Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer.
- Universal leukocyte reduction of blood transfusions.
- The intention-to-treat principle in clinical trials and meta-analyses of leukoreduced blood transfusions in surgical patients.
- Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion.
- Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery.
- The second century of ABO: and now for something completely different.
- The costs and consequences of management fads and politically driven regulatory oversight.
- The transfusion immunomodulation theory: the Th1/Th2 paradigm and an analogy with pregnancy as a unifying mechanism.
- Immunomodulation by blood transfusion: an evolving scientific and clinical challenge.
- Platelet transfusion - the new immunology of an old therapy.
- Breaking the mold: transcription factors in the anucleate platelet and platelet-derived microparticles.
- Storage Duration of Red Blood Cell Transfusion and Clostridium difficile Infection: A Within Person Comparison.
- Hospital variation in transfusion and infection after cardiac surgery: a cohort study.
- Does the storage duration of blood products affect outcomes in critically ill patients?
- Transfusion recipient epidemiology and outcomes research: possibilities for the future.
- Statin islands and PPAR ligands in platelets.
- Allogeneic blood transfusions explain increased mortality in women after coronary artery bypass graft surgery.
- Utilization of blood transfusion among older adults in the United States.
- Role of transfusion in the development of urinary tract-related bloodstream infection.
- Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes.
- Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-...
- Erythropoietin to treat anaemia in patients with head and neck cancer.
- Platelet proteome changes associated with diabetes and during platelet storage for transfusion.
- 15-deoxy-delta12,14-PGJ2 enhances platelet production from megakaryocytes.
- Increased risk of infection and mortality in women after cardiac surgery related to allogeneic blood transfusion.
- Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acut...
- Foxp3 regulates megakaryopoiesis and platelet function.
- Platelets as a novel target for PPARgamma ligands : implications for inflammation, diabetes, and cardiovascular disease.
- The mystery of transfusion-related acute lung injury.
- The platelet as a therapeutic target for treating vascular diseases and the role of eicosanoid and synthetic PPARgamma ligands.
- Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles.
- Optimizing platelet transfusion therapy.
- Developmental changes in soluble CD40 ligand.
- Platelets and megakaryocytes contain functional nuclear factor-kappaB.
- ABO-mismatched platelet transfusions and clinical outcomes after cardiac surgery.
- The causes and treatment of reactions to platelet transfusions.
- The Feverfew plant-derived compound, parthenolide enhances platelet production and attenuates platelet activation through NF-?B inhibition.
- Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes.
- ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stem cell transplantation.
- Leukocyte-reduced transfusions in cardiac surgery results of an implementation trial.
- WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization.
- An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions.
- Decreased sepsis related to indwelling venous access devices coincident with implementation of universal leukoreduction of blood transfusions.
Schools
George Washington University School Of Medicine
Sheppard Pratt Hospital
University MD
Doctors Specialties
- Psychiatry
- Pathology
Accepted Insurances
Education
-
Yale-New Haven Hospital -
Yale University School of Medicine -
Yale University -
Yale College
Hospital
-
Strong Memorial Hospital of the University of Rochester
Helpful Reviews
Similar Doctors
|
|
Dr. Ernest F. Cumerma, MD |
|
|
Dr. Christian H. Hansen, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alfred W. Forrester, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Silvia O. Williams, MD |